Welcome to our dedicated page for NantHealth news (Ticker: NH), a resource for investors and traders seeking the latest updates and insights on NantHealth stock.
Company Overview:
NantHealth Inc. (symbol: NH) is a pioneering healthcare technology company that is transforming the landscape of personalized healthcare. The company's mission is to optimize patient outcomes and enable value-based care through advancements in technology and precision medicine.
Core Business and Offerings:
NantHealth integrates novel diagnostics with large-scale biometric and phenotypic data to deliver truly personalized healthcare solutions. By adopting a systems-based approach, NantHealth enhances treatment decisions for critical illnesses, effectively improving patient outcomes.
Recent Achievements:
The company has made significant strides in deploying its precision medicine platforms, harnessing biometric and phenotypic data. These achievements underscore NantHealth's commitment to pushing the boundaries of personalized healthcare.
Current Projects:
NantHealth is actively involved in developing and refining its healthcare platforms. The focus is on integrating advanced diagnostics with data analytics to provide actionable insights that guide treatment options, ensuring better care for patients.
Financial Condition:
While specific financial details fluctuate with market activities and quarterly reports, NantHealth remains dedicated to its financial health and sustainable growth, continually seeking to advance its mission and technology.
Partnerships:
NantHealth collaborates with various healthcare providers, research institutions, and technology companies to enhance its offerings and expand its impact on the healthcare sector.
Significance:
NantHealth's unique approach to integrating diagnostics and data analytics sets it apart in the healthcare industry. Their commitment to precision medicine has made them a significant player in the quest for more effective and personalized treatments for critical illnesses.
NantHealth has achieved HITRUST certification for its NaviNet Open platform, solidifying its commitment to data security and regulatory compliance. This certification places NantHealth among an elite group globally recognized for their information security management. NaviNet Open enhances communication between providers, supporting over 500,000 users and facilitating more than 33 million transactions monthly. Senior VP Chris House emphasized that this certification demonstrates their leadership in healthcare IT and assures clients of high standards for data protection.
NantHealth reported Q4 2021 revenue of $16.0 million, a decline from $18.6 million in Q4 2020, with a gross margin of 57%. For the full year, revenue was $62.6 million, down from $73.2 million in 2020. The net loss for Q4 was $16.7 million ($0.14 per share), improving from $20.1 million ($0.18 per share) year-over-year. Noteworthy operational developments included the launch of Eviti Connect for Autoimmune Diseases and significant growth in the NaviNet AllPayer Advantage segment, which saw 17% year-over-year growth.
NantHealth, Inc. (NASDAQ: NH) will announce its 2021 fourth quarter and full year financial results on February 24, 2022, after market close. Following the announcement, the management will host a conference call at 1:30 p.m. PT (4:30 p.m. ET) to discuss performance details. Interested parties can join by calling 877-407-0312 from the U.S. or 201-389-0899 internationally, or listen via www.nanthealth.com.
NantHealth, Inc. (NASDAQ: NH) has launched its first OpenNMS Minion Appliance, enhancing the deployment of its monitoring system. This cloud-enabled appliance simplifies the setup and extension of OpenNMS Minion in remote networks. It features a user-friendly portal for configuration and diagnostics, along with automated updates. CEO David Hustace emphasizes its significance for growing corporate networks. Built with Azure IoT and Ubuntu Core, the appliance supports both current on-premise and future cloud solutions.
NantHealth (NASDAQ: NH) has announced that Maryland Physicians Care (MPC) will utilize its Eviti Connect for Autoimmune Diseases solution. This initiative aims to enhance drug authorization processes for members with chronic autoimmune conditions. The platform will improve visibility into drug costs, support reimbursements, and reduce denials while optimizing patient care.
Dr. Jonathan Keyser, Director of Pharmacy at MPC, emphasized the commitment to provide high-quality healthcare through innovative programs. NantHealth's COO Ron Louks noted that the collaboration aligns with their mission to improve patient care efficiency.
NantHealth, Inc. (NASDAQ: NH) announced participation in the 2021 Jefferies London Healthcare Conference. The event will feature virtual meetings with institutional investors on November 18 and 19, 2021. NantHealth aims to showcase its enterprise solutions that enable businesses to transform complex data into actionable insights across various sectors, including healthcare and life sciences. For scheduling meetings, interested parties should contact their Jefferies representative.
NantHealth, Inc. (NH) reported Q3 2021 net revenue of $14.4 million, down from $18.8 million in Q3 2020, attributed to contract expirations and initiations. Gross margin decreased to 52% from 60% year-over-year. SG&A expenses rose to $13.0 million, while R&D expenses slightly decreased to $4.6 million. The net loss narrowed to $10.8 million ($0.09 per share). Cash reserves stand at $45.5 million. NantHealth aims for a return to average revenue run rates in Q4 and continues to expand its Eviti Connect program, enhancing product offerings.
NantHealth, Inc. (NASDAQ: NH) has appointed three new executives to enhance its leadership team: Jerry Magin as Senior VP of Global Sales and Marketing, Neil Carpenter as Senior VP of Strategy, and Arlyn Small as Senior VP of Human Resources. Magin brings over 25 years of experience in building sales and marketing teams, Carpenter has extensive expertise in healthcare strategy, while Small has a strong background in HR across multiple sectors. These appointments aim to drive growth and innovation at NantHealth, as stated by COO Ron Louks.
NantHealth, Inc. (NASDAQ-GS: NH) will announce its 2021 third quarter financial results on November 4, 2021, after market close. The company will hold a conference call at 1:30 p.m. PT (4:30 p.m. ET) to discuss its performance. Interested parties can join the call by dialing 800-584-1507 for U.S. and Canada or 212-231-2902 for international access. The call will also be available online at nanthealth.com.
NantHealth has entered into a partnership with Care Continuity Inc. to enhance care logistics for patients with complex diseases, particularly focusing on cancer care pathways. The collaboration utilizes NantHealth's Eviti Connect platform, aiming to improve patient navigation through healthcare services. Key features include emergency discharge programs, inpatient discharge services, and high-touch care management. This partnership addresses challenges in patient self-navigation, ultimately striving for equal access to high-quality healthcare.
FAQ
What does NantHealth Inc. do?
What is NantHealth's mission?
What recent achievements has NantHealth made?
What are some of NantHealth's current projects?
Who are NantHealth's partners?
How does NantHealth impact the healthcare industry?
What makes NantHealth's approach unique?
Is there a focus on value-based care at NantHealth?
Where can I find more information about NantHealth?
How can I stay updated on NantHealth's latest developments?
